Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Lymphangioleiomyomatosis × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Tuberous Sclerosis 1 Prostatic Neoplasms 1 Perioperative Inflammatory Response 1 Multiple Myeloma 1 Lymphangioleiomyomatosis 1 Fibrosis 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Sirolimus 5 Everolimus 3 carbon-11 acetate 1 Sugars 1 Simvastatin 1 Resveratrol 1 Octreotide 1 Letrozole 1 Imatinib Mesylate 1 Hydroxychloroquine 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02061397 2020-08-25

SOS

University of Pennsylvania

Phase 1/2 Completed

10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡